A versatile bioink for printing human tissue models
Our bioink reduces the time and labor costs for drug development
EASY TO USE
Our bioink is always quality control tested for consistency, reproducibility, and sterility
Our bioinks can support a variety of specialized cell types and have associated protocols that are optimized for multiple bioprinters
The current drug-discovery process:
takes up to 20 years
costs $1.3-1.7 billion
has an 8% success rate
Axolotl Bioscience's TissuePrint is the solution through its reproducible neurobioink, versatile usability, and compatibility to patient's cells.
TissuePrint is a fibrin-based bioink which supports multiple different cell lines such as patient-derived human-induced pluripotent stem cells (hiPSCs), neural progenitor cells (NPCs), and mesenchymal stem cells (MSCs).
Our novel bioink is compatible with extrusion-based bioprinters from the likes of Cellink, Aspect Biosciences, and Allevi3D.
TissuePrint is a research-grade bioink, which generates stable and reproducible 3D-structures that can remain in culture for over a month. Not only does neurobioink allow for long-term culture but it also allows cells to maintain high viability and promotes neuronal differentiation.